- Home
- LAMR vs ASND Comparison
LAMR vs ASND Comparison
Compare LAMR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAMR
- ASND
- Stock Information
- Founded
- LAMR 1902
- ASND 2006
- Country
- LAMR United States
- ASND Denmark
- Employees
- LAMR N/A
- ASND N/A
- Industry
- LAMR Real Estate Investment Trusts
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- LAMR Real Estate
- ASND Health Care
- Exchange
- LAMR Nasdaq
- ASND Nasdaq
- Market Cap
- LAMR 12.1B
- ASND 10.6B
- IPO Year
- LAMR 1996
- ASND 2015
- Fundamental
- Price
- LAMR $125.07
- ASND $175.45
- Analyst Decision
- LAMR Buy
- ASND Strong Buy
- Analyst Count
- LAMR 6
- ASND 17
- Target Price
- LAMR $131.83
- ASND $222.18
- AVG Volume (30 Days)
- LAMR 572.0K
- ASND 429.4K
- Earning Date
- LAMR 08-08-2025
- ASND 09-02-2025
- Dividend Yield
- LAMR 4.95%
- ASND N/A
- EPS Growth
- LAMR N/A
- ASND N/A
- EPS
- LAMR 4.11
- ASND N/A
- Revenue
- LAMR $2,220,416,000.00
- ASND $398,509,511.00
- Revenue This Year
- LAMR $4.78
- ASND $77.19
- Revenue Next Year
- LAMR $3.54
- ASND $75.84
- P/E Ratio
- LAMR $30.57
- ASND N/A
- Revenue Growth
- LAMR 3.72
- ASND 12.06
- 52 Week Low
- LAMR $99.84
- ASND $111.09
- 52 Week High
- LAMR $139.88
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- LAMR 63.21
- ASND 54.14
- Support Level
- LAMR $121.89
- ASND $168.01
- Resistance Level
- LAMR $129.78
- ASND $180.00
- Average True Range (ATR)
- LAMR 2.97
- ASND 6.12
- MACD
- LAMR 0.24
- ASND -0.28
- Stochastic Oscillator
- LAMR 59.86
- ASND 59.33
About LAMR Lamar Advertising Company
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.